SOUTH SAN FRANCISCO, Calif., Feb. 14 /PRNewswire/ -- Onmark, a national group purchasing organization (GPO) for community-based practices and an OTN company, today announced that it has signed a new contract with Bristol-Myers Squibb for several multisource anti-cancer products.
"The continued expansion of Onmark's already-robust contract portfolio signifies that we have proven our value as a GPO to leading pharmaceutical companies," said Clark Avery, Vice President and General Manager of Onmark. "Over the last two years, we have become one of the largest GPOs for community-based practices, with more than 2,200 members. Our pharmaceutical partners recognize that we deliver value by providing a wealth of educational programs and tools that inform community-based physicians, nurses and practice administrators about the most appropriate and cost-effective use of pharmaceutical products."
Onmark has one of the broadest contract portfolios among all GPOs. It offers its members contracts from 16 leading pharmaceutical manufacturers, representing the majority of the most widely-used chemotherapy, biologic and supportive care agents, including both brand and generic products. Members who purchase through Onmark contracts have access to the most aggressive pricing available through OTN. For a listing of all pharmaceutical contracts and the products, services and educational programs available to Onmark members, visit www.onmarkservices.com.
OTN, a One Equity Partners portfolio company, is a leading physician services company that provides a broad set of customized solutions, including technology, pharmaceuticals, supportive care products and medical/surgical supplies, to physicians who practice in the community-based treatment setting. Through its innovative Lynx(TM) Technologies, practice management tools and unsurpassed customer service, OTN helps physicians remain independent and improve practice efficiency while enabling them to focus on providing optimal patient care. Through its specialty pharmacy, OTN provides physicians and their patients with efficient delivery of medications to treat cancer, as well as rheumatoid arthritis, infertility and other chronic conditions requiring the latest intravenous, injectable and oral medicines. OTN's affiliated group purchasing organization (GPO), Onmark, offers its members competitive contracts for oncology drugs and medical/surgical supplies, practice management tools and educational programs. For more information, please visit www.myOTN.com.
Onmark, an OTN company, is a leading national group purchasing organization (GPO) for community-based practices. It is one of the largest GPOs in the community-based setting, with more than 2,200 members representing more than 3,800 physicians and over $4 billion in annual drug purchases. Through strategic relationships with OTN, pharmaceutical companies and industry experts, Onmark provides its members with access to a full portfolio of competitive contracts for pharmaceutical products and medical/surgical supplies, the most aggressive pricing available through OTN, practice management resources, clinical tools and educational programs. For information about the products, services and programs available to Onmark members, visit www.onmarkservices.com.